Evofem Biosciences, Inc. (EVFM) Files 8-K Regarding Entry into a material definitive agreement

A Form 8-K filed by Evofem Biosciences, Inc. (EVFM) with the SEC on 2026-09-23 discloses entry into a material definitive agreement.

Public companies are required to file a Form 8-K with the SEC within four business days of a material corporate event, covering matters ranging from leadership changes to major agreements and financial results.

Investors can review the full filing directly through the SEC's EDGAR database for additional detail beyond what is summarized here.